Healthy Start vitamins: is a targeted or a universal approach more cost effective?
NICE has been requested to provide an analysis of the Healthy Start vitamin programme to determine whether it would be cost-effective to move from the current targeted approach to a universal offering. An expert reference group will be convened to develop a report which will be provided to the Chief Medical Officer. This special report is not intended to inform the development of a NICE guideline.
Living well for longer: preventing premature mortality
Local authorities have a key role to play in preventing and reducing premature deaths from non-communicable diseases such as cancer, heart disease, stroke, respiratory disease and alcohol-related liver conditions. By tackling these diseases, they will also help reduce health inequalities, because the more disadvantaged people are, the more likely they are to die before they reach 75. NICE has been producing evidence-based guidance on cost effective action to prevent disease and promote good health (public health guidance) since 2005. Living well for longer - Preventing premature mortality, summarises the actions local authorities can take to reduce premature mortality.
Blood alcohol concentration
Two special reports produced by NICE, on behalf of the Department for Transport focus on reducing the number of alcohol-related road deaths. The reports examine the potential effects of reducing the UK's legal blood alcohol concentration (BAC) limit.
Health systems and health related behaviour change
In 2010 NICE, working with the World Health Organisation, produced this special report on health systems and health related behaviour change. It presents a review and analysis of evidence from research literature, NICE public health guidance, and NICE public health stakeholder responses about features of health and public health systems that promote and support health related behaviour change.
Supporting local investment in public health
Making the case for investing in public health interventions is much easier when information about cost-effectiveness and cost impact is available. But how can the potential return on investment be demonstrated?
NICE set up a cost impact project to explore its approaches to assessing the cost effectiveness and cost impact of public health interventions, in response to growing demand from local commissioners and others, such as directors of public health, involved in making investment decisions.
The report summarises potential new methods for determining the cost impact of - and returns on investment (ROI) from - public health intervention recommendations made by NICE.
The project explored the feasibility and usefulness of producing a range of cost effectiveness and cost impact/ROI data and tools to support local decision-making.
The study showed that a wide range of different metrics and tools are needed to support effective decision making at a local level, and the report contains a series of recommendations for taking this forward.
Return on Investment tools
The return on investment tools have been designed to support investment decisions by commissioners and policy makers in local authorities and the NHS.